| Authors: |
Nichetti F; Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. federico.nichetti@iov.veneto.it.; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany. federico.nichetti@iov.veneto.it., Hüllein J; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., du Rusquec P; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research unit, Institut Curie, Saint-Cloud, France., Pleasance E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada., Chen L; Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Mock A; Institute of Pathology, University of Munich (LMU), Munich, Germany., Horak P; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ambrosini P; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Rota S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Agnelli L; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Tinè G; Biostatistics for Clinical Research Unit, Epidemiology and Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy., Edelmann D; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; NCT Trial Center, National Center for Tumor Diseases, Heidelberg, Germany., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research unit, Institut Curie, Saint-Cloud, France.; Paris-Saclay University, Paris, France., Laskin J; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Pruneri G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Wang C; Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Hübschmann D; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany., de Braud F; Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Fröhling S; German Cancer Consortium (DKTK), Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mariani L; Biostatistics for Clinical Research Unit, Epidemiology and Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy. |
